In contrast, CTNNB1 mutations are significantly different in low-grade ovarian endometrioid carcinomas (53%) compared to 28% of the low-grade endometrial endometrioid carcinomas [4]. This evidence concerns the gene CTNNB1 and ovarian endometrioid carcinoma.